Home   Logon   Mobile Site   Research and Commentary   About Us   Call 1.800.621.1675 or Email Us       Follow Us: 

Search by Ticker, Keyword or CUSIP       
 
 
First Trust Nasdaq Pharmaceuticals ETF (FTXH)
Holdings of the Fund as of 12/6/2022
View Index Holdings

Total Number of Holdings (excluding cash): 29

Security Name Identifier CUSIP Classification Shares / Quantity Market Value Weighting Descending sort
Gilead Sciences, Inc. GILD 375558103 Pharmaceuticals 48,492 $4,265,356.32 9.89%
Bristol-Myers Squibb Company BMY 110122108 Pharmaceuticals 45,658 $3,648,987.36 8.46%
Amgen Inc. AMGN 031162100 Pharmaceuticals 12,808 $3,628,378.32 8.41%
Ironwood Pharmaceuticals, Inc. IRWD 46333X108 Pharmaceuticals 286,041 $3,406,748.31 7.90%
Johnson & Johnson JNJ 478160104 Pharmaceuticals 19,076 $3,359,283.60 7.79%
Merck & Co., Inc. MRK 58933Y105 Pharmaceuticals 18,029 $1,963,898.97 4.55%
Eli Lilly and Company LLY 532457108 Pharmaceuticals 5,109 $1,882,870.86 4.37%
United Therapeutics Corporation UTHR 91307C102 Pharmaceuticals 6,791 $1,878,390.60 4.36%
AbbVie Inc. ABBV 00287Y109 Pharmaceuticals 11,445 $1,873,775.40 4.35%
Prestige Consumer Healthcare Inc. PBH 74112D101 Pharmaceuticals 30,425 $1,851,665.50 4.29%
Viatris Inc. VTRS 92556V106 Pharmaceuticals 161,141 $1,761,271.13 4.08%
Cardinal Health, Inc. CAH 14149Y108 Pharmaceuticals 21,761 $1,727,823.40 4.01%
Vertex Pharmaceuticals Incorporated VRTX 92532F100 Pharmaceuticals 5,462 $1,703,106.22 3.95%
Pfizer Inc. PFE 717081103 Pharmaceuticals 34,024 $1,691,333.04 3.92%
Organon & Co. OGN 68622V106 Pharmaceuticals 53,940 $1,410,531.00 3.27%
Horizon Therapeutics Plc HZNP G46188101 Pharmaceuticals 9,282 $898,961.70 2.08%
BioMarin Pharmaceutical Inc. BMRN 09061G101 Pharmaceuticals 6,162 $629,879.64 1.46%
Alkermes Plc ALKS G01767105 Pharmaceuticals 23,220 $580,500.00 1.35%
Zoetis Inc. ZTS 98978V103 Pharmaceuticals 3,511 $537,358.55 1.25%
Jazz Pharmaceuticals Plc JAZZ G50871105 Pharmaceuticals 3,541 $530,902.13 1.23%
Ionis Pharmaceuticals, Inc. IONS 462222100 Pharmaceuticals 12,926 $491,575.78 1.14%
Pacira BioSciences, Inc. PCRX 695127100 Pharmaceuticals 10,473 $491,916.81 1.14%
Corcept Therapeutics Incorporated CORT 218352102 Pharmaceuticals 21,286 $486,597.96 1.13%
Perrigo Company Plc PRGO G97822103 Pharmaceuticals 14,688 $466,050.24 1.08%
Elanco Animal Health Incorporated ELAN 28414H103 Pharmaceuticals 36,326 $456,617.82 1.06%
Seagen Inc. SGEN 81181C104 Pharmaceuticals 3,562 $419,995.42 0.97%
Blueprint Medicines Corporation BPMC 09627Y109 Pharmaceuticals 7,506 $364,116.06 0.84%
Catalent, Inc. CTLT 148806102 Pharmaceuticals 6,245 $301,133.90 0.70%
Emergent BioSolutions Inc. EBS 29089Q105 Pharmaceuticals 22,881 $278,919.39 0.65%
US Dollar $USD Other 131,449 $131,448.59 0.30%
Holdings are subject to change.

The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.


 
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
First Trust Portfolios L.P.  Member SIPC and FINRA. (Form CRS)   •  First Trust Advisors L.P. (Form CRS)
Home |  Important Legal Information |  Privacy Policy |  California Privacy Policy |  Business Continuity Plan |  FINRA BrokerCheck
Copyright © 2022 All rights reserved.